Who owns Osiris Therapeutics?

Key details on Osiris Therapeutics (Ticker: OSIR)

Who owns Osiris Therapeutics?

Is OSIR a good stock to own? Find out who bought Osiris Therapeutics, who sold Osiris Therapeutics (OSIR) stock, and who holds a large position in Osiris Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 2.24M $29.40M March 31, 2014
Consonance Capital 2.06M $26.98M March 31, 2014
BlackRock Fund Advisors 884979 $11.62M March 31, 2014
BlackRock Institutional Trust Company, N.A. 615619 $8.08M March 31, 2014
Vanguard 588372 $7.72M March 31, 2014
SUSQUEHANNA INTERNATIONAL 370219 $4.86M March 31, 2014
Baker Bros. Advisors 361530 $4.75M March 31, 2014
Dr. Jeffrey R. Jay, M.D 357800 $3.94M June 30, 2012
Inves 323250 $5.38M Sept. 30, 2013
STATE STREET CORPORATION 281795 $3.70M March 31, 2014
LORD, ABBETT & CO 257528 $4.14M Dec. 31, 2013
Roxbury Capital Management 253600 $2.64M March 31, 2013
Hood River Capital Management 252273 $2.54M June 30, 2013
NORTHERN TRUST 245463 $3.23M March 31, 2014
PUTNAM INVESTMENTS 142200 $0 Dec. 31, 2013
Ascend Capital 115000 $1.27M Sept. 30, 2012
Cormorant Asset Management 107800 $1.73M Dec. 31, 2013
GSA Capital Partners 95396 $985440 March 31, 2013
Geode Capital Management 91311 $1.20M March 31, 2014
GROUP ONE TRADING 86474 $1.14M March 31, 2014
MORGAN STANLEY 83848 $1.37M Sept. 30, 2013
Barclays 82503 $1.07M March 31, 2014
HUNTINGTON NATIONAL BANK 82000 $1.08M March 31, 2014
Bridgeway Capital Management 80200 $886210 Sept. 30, 2012
TIAA-CREF Investment Management 72208 $948091 March 31, 2014
ESSEX INVESTMENT MANAGEMENT 68083 $1.09M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 64982 $853213 March 31, 2014
Credit Suisse AG 59447 $1.49M March 31, 2014
Bank of America Corporation 57509 $958675 Sept. 30, 2013
Eudaimonia Asset Management 54875 $605820 Sept. 30, 2012
Renaissance Technologies 51807 $538792 March 31, 2013
Accipiter Capital Management 50000 $804000 Dec. 31, 2013
Batterymarch Financial Management 48241 $633886 March 31, 2014
UBS AG 46242 $507274 June 30, 2012
ALLIANCEBERNSTEIN 45923 $764158 Sept. 30, 2013
BlackRock Investment Management 45744 $601076 March 31, 2014
Jefferies 45663 $734717 Dec. 31, 2013
Oxford Asset Management 42787 $444984 March 31, 2013
ProShare Advisors 42694 $560999 March 31, 2014

Who sold Osiris Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Jacobs Levy Equity Management Sept. 30, 2011 50154 $256788
WOODSTOCK March 31, 2011 50839 $369091
CalPERS March 31, 2011 46310 $336210